文献速递关节外科

非阿片类镇痛药用于全关节置换术后疼痛管理:系统综述与荟萃分析

Non-Opioid Analgesics for Postoperative Pain Management Following Total Joint Arthroplasty: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Arthroplasty · 2025-03-15

该系统综述与荟萃分析检索OVID、Embase、Medline和PubMed,纳入接受关节置换术并术后使用非阿片类辅助镇痛药的患者,分析多种药物及类别在多个术后时间点对疼痛评分和阿片类药物用量的影响,共纳入28项分析。结果显示非阿片类辅助镇痛可能减少阿片类药物需求并对术后疼痛有适度保护作用,但对疼痛的临床意义可能有限。

要点

  • 非甾体抗炎药(NSAIDs)和加巴喷丁类药物平均分别减少24小时内静脉吗啡9.30 mg和10.89 mg。
  • NSAIDs在术后第1天及第3、5天改善静息痛,parecoxib和皮质类固醇在术后第3天有保护作用。
  • NSAIDs在6小时及术后第1、2、3天显著减轻运动痛,parecoxib在术后第1天及第2至3天有类似获益。

核心结论

  • 术后使用非阿片类辅助镇痛可能减轻对阿片类药物的需求,并对术后疼痛有适度保护作用。
  • 这些镇痛药对减轻疼痛的效应可能无临床意义。
  • 结果可能进一步提示需要在术后患者护理中实施非阿片类辅助镇痛。
  • 未来研究可包括随着更多药物颗粒度研究可用时对本研究问题进行更新调查。

研究设计与样本

  • 系统检索OVID、Embase、Medline和PubMed,筛选接受关节置换术并术后使用非阿片类镇痛药的患者试验。
  • 进行多项荟萃分析,探讨不同药物及类别在多个术后时间点对疼痛评分和阿片类药物用量的影响。
  • 涉及一种以上疼痛测量指标的分析采用标准化均数差。
  • 最终综述纳入28项分析。

主要发现

  • 平均而言,非甾体抗炎药(NSAIDs)和加巴喷丁类药物在24小时内分别减少静脉吗啡9.30 mg和10.89 mg。
  • NSAIDs、加巴喷丁类药物、parecoxib和pregabalin在多个时间点也观察到减少。
  • 非阿片类辅助镇痛在多个时间点改善静息痛,包括NSAIDs在术后第1天及第3、5天。
  • parecoxib和皮质类固醇在术后第3天有保护作用。
  • NSAIDs在6小时及术后第1、2、3天显著减轻运动痛,parecoxib在术后第1天及第2至3天显示类似获益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这些镇痛药对减轻疼痛的效应可能无临床意义。
  • 未来研究可包括随着更多药物颗粒度研究可用时对本研究问题进行更新调查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hip and knee arthroplasty are a fundamental part of modern orthopaedic practice. These procedures often require extensive postoperative analgesia, including opiate painkillers that are frequently associated with adverse side effects and risk of abuse. This review, therefore, investigated how postoperative administration of nonopioid coanalgesics (e.g., parecoxib, pregabalin) can affect postoperative pain scores and opioid use. METHODS: A systematic search of OVID, Embase, Medline, and PubMed was conducted, and studies were filtered to trials of patients undergoing arthroplasty who received nonopioid analgesia. Several meta-analyses were conducted to investigate the effects of various medications and classes at multiple postoperative time points on pain scores and opioid use. Standardized mean differences were conducted for analyses involving more than one measure of pain. There were 28 analyses included in the final review. RESULTS: On average, nonsteroidal anti-inflammatory drugs (NSAIDs) and gabapentinoids reduced between 9.30 and 10.89 mg, respectively of intravenous morphine in a 24-hour period. Reductions were also observed at various time points for NSAIDs, gabapentinoids, parecoxib, and pregabalin. Nonopioid coanalgesia improved pain at rest for various time points, including NSAIDs at postoperative day (POD) 1 and PODs 3 and 5. Parecoxib and corticosteroids were protective at POD 3. Pain during movement was significantly reduced by NSAIDs at 6 hours, POD 1, 2, and 3, with parecoxib demonstrating similar benefits at POD 1 and POD 2 to 3. CONCLUSIONS: This review found that postoperative administration of nonopioid coanalgesia may alleviate the need for opioids and have modest protective effects on postoperative pain. The effects of these analgesics, however, may be clinically nonmeaningful for reducing pain. These results may further implicate a need to implement nonopioid coanalgesia in postoperative patient care. Future research may include an updated investigation of this research question as more medication granular research becomes available.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Syed IM, Al-Rubaie S, Cohen D, et al. Non-Opioid Analgesics for Postoperative Pain Management Following Total Joint Arthroplasty: A Systematic Review and Meta-Analysis. J Arthroplasty. 2025. PMID: 40090504. doi:10.1016/j.arth.2025.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。